Kansas City Clinical Oncology Program

堪萨斯城临床肿瘤学项目

• 批准号: 8790673
• 负责人: Rakesh Gaur
• 金额: $ 63.78万
• 依托单位: NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2019-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8790673
• 关键词: Adoption; Advanced Malignant Neoplasm; Advocate; Ally; Area; Behavioral; Behavioral Sciences; Cancer Control; Caring; Cities; Client satisfaction; Clinical Oncology; Clinical Trials; Clinical Trials Network; Communities; Community Participation; Conduct Clinical Trials; County; Development; Early Diagnosis; Elderly; Equilibrium; Evidence Based Medicine; Fostering; Funding; Gastroenterology; Genetic Counseling; Gynecologic Oncology; Health; Healthcare; Home environment; Hospital Administrators; Hospitals; Image; Individual; Informatics; Internal Medicine; Kansas; Laboratories; Malignant Neoplasms; Measures; Medical; Medical Oncology; Minority; Mission; Missouri; Monitor; National Cancer Institute; Neighborhoods; Neurology; Nonprofit Organizations; Oncologist; Outcomes Research; Palliative Care; Participant; Patient Participation; Patients; Pharmacogenomics; Physicians; Population; Population Heterogeneity; Prevention; Primary Health Care; Protocols documentation; Quality of life; Radiation Oncology; Radiology Specialty; Rehabilitation therapy; Reporting; Research; Research Personnel; Risk Factors; Safety; Science; Screening for cancer; Services; Southwest Oncology Group; Structure; Surgical Oncology; Symptoms; Technology; Travel; Underserved Population; Woman; base; cancer care; cancer prevention; cancer therapy; care delivery; cellular pathology; cultural values; medical specialties; metropolitan; oncology program; outreach; programs; public health relevance; research and development; research study; screening; social; surveillance study; survivorship; trend; volunteer

DESCRIPTION (provided by applicant): The Kansas City Clinical Oncology Program (KCCOP) expects to transition to NCORP-KC. It is a very successful non-profit organization conducting clinical trials in cancer therapy, cancer symptom prevention. Quality of Life, and cancer control since 1983 with uninterrupted funding by the National Cancer Institute. The program is located in the Kansas City metropolitan area and serves the needs of both Kansas and Missouri residents spread over 16 counties and 2.5 million citizens. The program is comprised of seven component area hospitals and 52 investigators representing specialties well beyond medical, surgical, gynecologic, and radiation oncology. The other areas of expertise include outcomes research, internal medicine, healthcare administration, healthcare informatics, behavioral science, rehabilitation and survivorship, palliative care, neurology, gastroenterology, genetic counseling, pathology, cellular therapy, laboratory science, and radiology. The program has provided participation opportunities to over 4,200 patients and volunteers in cancer-related trials since its inception. Over the last five years, an average of 235 new individuals have participated per year. The program has maintained excellent quality of research as confirmed by patient satisfaction and reports from external audits. The program derives its cancer trials from SWOG, NRG, ALLIANCE, CTSU, MD Anderson, URCC, and SunCoast research bases of the National Cancer Institute. NCORP-KC wishes to thank its participants and extend its service by entering a new era of Cancer Care Delivery Research while continuing to conduct high quality trials in cancer therapy, cancer control, screening, imaging, and post-therapy surveillance. The program monitors trends and implements measures for continued improvement. It balances protecting patients, their safety, and health with providing the broadest possible access to trial activation and minority outreach participation with the help of a highly responsive and responsible support staff.

描述（由申请人提供）：堪萨斯城临床肿瘤学计划 (KCCOP) 预计过渡到 NCORP-KC。它是一个非常成功的非营利组织，在癌症治疗、癌症症状预防方面开展临床试验。 自 1983 年以来，在国家癌症研究所的不间断资助下，我们致力于提高生活质量和癌症控制。 该项目位于堪萨斯城大都市区，满足堪萨斯州和密苏里州 16 个县居民和 250 万公民的需求。该项目由七家附属地区医院和 52 名研究人员组成，他们的专业领域远远超出了内科、外科、妇科和放射肿瘤学。其他专业领域包括结果研究、内科、医疗保健管理、医疗保健信息学、行为科学、康复和生存、姑息治疗、神经病学、胃肠病学、遗传咨询、病理学、细胞治疗、实验室科学和放射学。 该计划自启动以来已为 4,200 多名患者和志愿者提供了参与癌症相关试验的机会。过去五年，平均每年有 235 名新人参与。该计划保持了卓越的研究质量，患者满意度和外部审计报告证实了这一点。该计划的癌症试验源自国家癌症研究所的 SWOG、NRG、ALLIANCE、CTSU、MD Anderson、URCC 和 SunCoast 研究基地。 NCORP-KC 希望感谢其参与者，并通过进入癌症护理研究的新时代来扩展其服务，同时继续在癌症治疗、癌症控制、筛查、成像和治疗后监测方面进行高质量的试验。 该计划监控趋势并实施持续改进措施。它在保护患者及其安全和健康与提供尽可能广泛的试验启动和少数群体外展参与之间取得平衡 在高度反应和负责任的支持人员的帮助下。